Form 4 for CYRX Cryoport, Inc.
Accepted 2021-08-13 00:00:00 ET · period of report 2021-08-11 · accession 0001104659-21-105168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-13 | 2021-08-11 | CYRX | Sawicki Mark W | CSO | S - Sale+OE | $58.45 | -80.1K | 52.6K | -60% | -$4.68M |
| DM | 2021-08-13 | 2021-08-11 | CYRX | Sawicki Mark W | CSO | M - OptEx | $7.95 | +94.2K | 113.7K | +483% | +$748.9K |
| DM | 2021-08-13 | 2021-08-11 | CYRX | Sawicki Mark W | CSO | M - OptEx | $0.00 | -94.2K | 51.4K | -65% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-11 | S | D | 74,453 | $58.37 | 55,822 | D | — | — | (F3) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.85 to $58.84, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 2 | Common | Common Stock | 2021-08-11 | M | A | 16,577 | $8.65 | 130,275 | D | — | — | |
| 3 | Common | Common Stock | 2021-08-11 | M | A | 77,625 | $7.80 | 113,698 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-11 | S | D | 2,521 | $59.83 | 50,129 | D | — | — | (F5) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.81 to $59.90, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 5 | Common | Common Stock | 2021-08-11 | S | D | 3,172 | $59.11 | 52,650 | D | — | — | (F4) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.85 to $59.51, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
| 6 | Derivative | Option to purchase common stock | 2021-08-11 | M | D | 77,625 | $0.00 | 0 | D | $7.80 · — to 2025-05-07 | 77,625 Common Stock | (F1) 1/48 of the 77,625 options originally granted vested on the 7th of each month for forty-eight months beginning June 7, 2015. |
| 7 | Derivative | Option to purchase common stock | 2021-08-11 | M | D | 16,577 | $0.00 | 51,423 | D | $8.65 · — to 2028-03-28 | 16,577 Common Stock | (F2) 1/48 of the 68,000 options originally granted vested on the 28th of each month for forty-eight months beginning April 28, 2018. |